Memory Impairment - Pipeline Review, H2 2014 On 10th December 2014
Summary Global Markets Directs, Memory Impairment - Pipeline Review, H2 2014, provides an overview of the Memory Impairments therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Memory Impairment, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Memory Impairment and special features on latestage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope - The report provides a snapshot of the global therapeutic landscape of Memory Impairment - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Memory Impairment and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Memory Impairment products under development by companies and universities/research institutes based on information derived from company and industryspecific sources - Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages - A detailed assessment of monotherapy and combination therapy pipeline projects - Coverage of the Memory Impairment pipeline on the basis of target, MoA, route of administration and molecule type - Latest news and deals relating related to pipeline products Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Memory Impairment - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Memory Impairment pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Other industries we cover: • • • • • • • •
Advertising and Media Automotive and Parts Consumer Goods Healthcare and Medical Finance and Banking Food and Beverages Travel and Tourism Textiles and Clothing
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
•
SWOT Analysis
Discounts on Market Research Reports till 31st December, 2014 For more inquiries, contact at +91 - 998 729 5242 / contact@jsbmarketresearch.com Table of Content List of Tables 5 List of Figures 5 Introduction 6 Global Markets Direct Report Coverage 6 Memory Impairment Overview 7 Therapeutics Development 8 Pipeline Products for Memory Impairment - Overview 8 Pipeline Products for Memory Impairment - Comparative Analysis 9 Memory Impairment - Therapeutics under Development by Companies 10 Memory Impairment - Therapeutics under Investigation by Universities/Institutes 11 Memory Impairment - Pipeline Products Glance 12 Clinical Stage Products 12 Early Stage Products 13 Memory Impairment - Products under Development by Companies 14 Memory Impairment - Products under Investigation by Universities/Institutes 15 Memory Impairment - Companies Involved in Therapeutics Development 16 Dart NeuroScience LLC 16 M et P Pharma AG 17 Neuren Pharmaceuticals Limited 18 Omeros Corporation 19 Sunovion Pharmaceuticals Inc. 20 Memory Impairment - Therapeutics Assessment 21 Assessment by Monotherapy Products 21 Assessment by Target 22 Assessment by Mechanism of Action 24 Assessment by Route of Administration 26 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Assessment by Molecule Type 28 Drug Profiles 30 2-PMPA - Drug Profile 30 Product Description 30 Mechanism of Action 30 R&D Progress 30 AC-253 - Drug Profile 31 Product Description 31 Mechanism of Action 31 R&D Progress 31 Antisense Oligonucleotide to Inhibit microRNA for Neurology - Drug Profile 32 Product Description 32 Mechanism of Action 32 R&D Progress 32 dehydroevodiamine hydrochloride - Drug Profile 33 Product Description 33 Mechanism of Action 33 R&D Progress 33 Drug for Memory Impairment - Drug Profile 34 Product Description 34 Mechanism of Action 34 R&D Progress 34 HT-3951 - Drug Profile 35 Product Description 35 Mechanism of Action 35 R&D Progress 35 NNZ-2591 - Drug Profile 36 Product Description 36 Mechanism of Action 36 R&D Progress 36 pregnenolone succinate - Drug Profile 38 Product Description 38 Mechanism of Action 38 R&D Progress 38 Small Molecule 2 to Inhibit PDE4 for Memory Impairment - Drug Profile 39 Product Description 39 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Mechanism of Action 39 R&D Progress 39 Small Molecule to Activate LPL for CNS and Metabolic Disorders - Drug Profile 40 Product Description 40 Mechanism of Action 40 R&D Progress 40 Small Molecule to Inhibit D-amino acid oxidase for Neuropathic Pain, Inflammatory Pain and Memory Impairment - Drug Profile 41 Product Description 41 Mechanism of Action 41 R&D Progress 41 Small Molecule to Inhibit MAO-B for Memory Impairment - Drug Profile 42 Product Description 42 Mechanism of Action 42 R&D Progress 42 Small Molecule to Inhibit PDE4 for Memory Impairment - Drug Profile 43 Product Description 43 Mechanism of Action 43 R&D Progress 43 Small Molecule to Target GPR83 for CNS and Immunological Disorders - Drug Profile 44 Product Description 44 Mechanism of Action 44 R&D Progress 44 Small Molecules to Activate Carbonic Anhydrase for Learning and Memory Impairment - Drug Profile 45 Product Description 45 Mechanism of Action 45 R&D Progress 45 Small Molecules to Activate PKC for CNS and Oncology - Drug Profile 46 Product Description 46 Mechanism of Action 46 R&D Progress 46 Small Molecules to Antagonize GALR3 for Memory Impairment - Drug Profile 47 Product Description 47 Mechanism of Action 47 R&D Progress 47 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Stem Cell Therapy for Memory Impairment and Brain Diseases - Drug Profile 48 Product Description 48 Mechanism of Action 48 R&D Progress 48 Memory Impairment - Recent Pipeline Updates 49 Memory Impairment - Dormant Projects 50 Appendix 51 Methodology 51 Coverage 51 Secondary Research 51 Primary Research 51 Expert Panel Validation 51 Contact Us 52 Disclaimer 52 List Of Tables Number of Products under Development for Memory Impairment, H2 2014 8 Number of Products under Development for Memory Impairment - Comparative Analysis, H2 2014 9 Number of Products under Development by Companies, H2 2014 10 Number of Products under Investigation by Universities/Institutes, H2 2014 11 Comparative Analysis by Clinical Stage Development, H2 2014 12 Comparative Analysis by Early Stage Development, H2 2014 13 Products under Development by Companies, H2 2014 14 Products under Investigation by Universities/Institutes, H2 2014 15 Memory Impairment - Pipeline by Dart NeuroScience LLC, H2 2014 16 Memory Impairment - Pipeline by M et P Pharma AG, H2 2014 17 Memory Impairment - Pipeline by Neuren Pharmaceuticals Limited, H2 2014 18 Memory Impairment - Pipeline by Omeros Corporation, H2 2014 19 Memory Impairment - Pipeline by Sunovion Pharmaceuticals Inc., H2 2014 20 Assessment by Monotherapy Products, H2 2014 21 Number of Products by Stage and Target, H2 2014 23 Number of Products by Stage and Mechanism of Action, H2 2014 25 Number of Products by Stage and Route of Administration, H2 2014 27 Number of Products by Stage and Molecule Type, H2 2014 29 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Memory Impairment Therapeutics - Recent Pipeline Updates, H2 2014 49 Memory Impairment - Dormant Projects, H2 2014 50 List Of Figures Number of Products under Development for Memory Impairment, H2 2014 8 Number of Products under Development for Memory Impairment - Comparative Analysis, H2 2014 9 Number of Products under Development by Companies, H2 2014 10 Number of Products under Investigation by Universities/Institutes, H2 2014 11 Comparative Analysis by Early Stage Products, H2 2014 13 Assessment by Monotherapy Products, H2 2014 21 Number of Products by Top 10 Targets, H2 2014 22 Number of Products by Stage and Top 10 Targets, H2 2014 23 Number of Products by Top 10 Mechanism of Actions, H2 2014 24 Number of Products by Stage and Top 10 Mechanism of Actions, H2 2014 25 Number of Products by Top 10 Routes of Administration, H2 2014 26 Number of Products by Stage and Top 10 Routes of Administration, H2 2014 27 Number of Products by Top 10 Molecule Types, H2 2014 28 Number of Products by Stage and Top 10 Molecule Types, H2 2014 29
Report Price: Licence Type
Price
$ 2000
Site Licence
$ 4000
Enterprise Wide Licence
$ 6000
Related Reports: BIOCAD - Product Pipeline Review - 2014 Biosceptre International Limited - Product Pipeline Review - 2014 Bioversys AG - Product Pipeline Review - 2014 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Cellmid Limited - Product Pipeline Review - 2014 centrose llc - Product Pipeline Review - 2014 ChironWells GmbH - Product Pipeline Review - 2014 DesignMedix, Inc. - Product Pipeline Review - 2014 Diurnal Ltd - Product Pipeline Review - 2014 Domain Therapeutics SA - Product Pipeline Review - 2014 Ecrins Therapeutics SAS - Product Pipeline Review - 2014
You can order this report by calling on +91 - 998 7295 242 or mail us your contact details at contact@jsbmarketresearch.com About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along with providing in-depth analysis though reports, JSB market research also provides regular updates of the market though newsletters. Our reports are a well-researched work of market researchers with an extensive knowledge and a good level of market experience.
To know more on Memory Impairment - Pipeline Review, H2 2014 http://www.jsbmarketresearch.com/healthcare-medical/r-memoryimpairment-pipeline-review-h2-2014-140030
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/